Asia-Pacific MRD Testing Market: Analysis and Forecast, 2023-2033
Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request.
This report will be delivered in 1-5 working days.
Introduction to Asia-Pacific MRD Testing Market
The Asia-Pacific MRD testing market is projected to reach $1.33 billion by 2033 from $0.30 billion in 2023, growing at a CAGR of 16.06% during the forecast period 2023-2033. The MRD testing market is expanding due to several reasons, including the expansion of Medicare coverage for MRD testing and its application in diagnosing solid tumors. Increased consumer awareness has led to a heightened demand for MRD testing. Healthcare practitioners and researchers are recognizing this trend and endeavouring to integrate MRD testing into clinical practices to address patient needs.
Market Introduction
The Asia-Pacific (APAC) MRD testing market is witnessing significant growth driven by various factors. This includes the extension of healthcare coverage for MRD testing and its emerging role in diagnosing solid tumors. Increasing awareness among consumers has led to a surge in demand for MRD testing across the region. Healthcare professionals and researchers are recognizing this trend and actively working to incorporate MRD testing into routine clinical procedures to meet patient needs effectively. Additionally, advancements in technology and healthcare infrastructure in key APAC countries further contribute to the expansion of the MRD testing market. With a growing emphasis on early detection and precision medicine, the APAC region presents substantial opportunities for MRD testing providers and stakeholders.
Market Segmentation:
Segmentation 1: by End User
Growth/Marketing Strategy: The APAC MRD testing market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint venture. The favored strategy for the companies has been partnerships and collaborations to strengthen their position in the MRD testing market.
Competitive Strategy: Key players in the APAC MRD testing market analyzed and profiled in the study involve major residual testing-based companies and test manufacturers. Moreover, a detailed competitive benchmarking of the players operating in the APAC MRD testing market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.
This report will be delivered in 1-5 working days.
Introduction to Asia-Pacific MRD Testing Market
The Asia-Pacific MRD testing market is projected to reach $1.33 billion by 2033 from $0.30 billion in 2023, growing at a CAGR of 16.06% during the forecast period 2023-2033. The MRD testing market is expanding due to several reasons, including the expansion of Medicare coverage for MRD testing and its application in diagnosing solid tumors. Increased consumer awareness has led to a heightened demand for MRD testing. Healthcare practitioners and researchers are recognizing this trend and endeavouring to integrate MRD testing into clinical practices to address patient needs.
Market Introduction
The Asia-Pacific (APAC) MRD testing market is witnessing significant growth driven by various factors. This includes the extension of healthcare coverage for MRD testing and its emerging role in diagnosing solid tumors. Increasing awareness among consumers has led to a surge in demand for MRD testing across the region. Healthcare professionals and researchers are recognizing this trend and actively working to incorporate MRD testing into routine clinical procedures to meet patient needs effectively. Additionally, advancements in technology and healthcare infrastructure in key APAC countries further contribute to the expansion of the MRD testing market. With a growing emphasis on early detection and precision medicine, the APAC region presents substantial opportunities for MRD testing providers and stakeholders.
Market Segmentation:
Segmentation 1: by End User
- Hospitals and Speciality Clinics
- Research Institutions
- Diagnostic Laboratories
- Other End Users
- China
- India
- Japan
- South Korea
- Australia
- Singapore
- Rest-of-Asia-Pacific
Growth/Marketing Strategy: The APAC MRD testing market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint venture. The favored strategy for the companies has been partnerships and collaborations to strengthen their position in the MRD testing market.
Competitive Strategy: Key players in the APAC MRD testing market analyzed and profiled in the study involve major residual testing-based companies and test manufacturers. Moreover, a detailed competitive benchmarking of the players operating in the APAC MRD testing market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.
Executive Summary
1 MARKETS
1.1 Market Scope
1.1.1 Key Questions Answered in the Report
1.2 Research Methodology
1.2.1 MRD Testing Market: Research Methodology
1.2.2 Data Sources
1.3 Market Estimation Model
1.3.1 Criteria for Company Profiling
2 MARKET OVERVIEW
2.1 MRD Testing Workflow Analysis
2.2 MRD Testing: Solid Tumor vs. Hematological Malignancy
2.3 Evolution of MRD Testing
2.4 Market Footprint
2.5 Market Size and Future Growth Potential
3 INDUSTRY INSIGHTS
3.1 Legal and Regulatory Framework of MRD Tests
3.1.1 Asia-Pacific
3.2 Reimbursement Scenario
3.2.1 Asia-Pacific
3.3 Supply Chain Analysis
3.3.1 For Laboratory Developed Tests (LDTs)
3.3.2 For In-Vitro Diagnostics (IVDs)
4 MINIMAL RESIDUAL DISEASE TESTING MARKET (BY REGION), 2022-2033
4.1 Overview
4.2 Asia-Pacific
4.2.1 Asia-Pacific MRD Testing Market, by End User
4.2.2 Asia-Pacific MRD Testing Market, by Country
5 COMPANY PROFILES
5.1 Overview
5.2 Sysmex Corporation
5.2.1 Company Overview
5.2.2 Role of Sysmex Corporation in the MRD Testing Market
5.2.3 Financials
5.2.4 Analyst Perspective
1 MARKETS
1.1 Market Scope
1.1.1 Key Questions Answered in the Report
1.2 Research Methodology
1.2.1 MRD Testing Market: Research Methodology
1.2.2 Data Sources
1.3 Market Estimation Model
1.3.1 Criteria for Company Profiling
2 MARKET OVERVIEW
2.1 MRD Testing Workflow Analysis
2.2 MRD Testing: Solid Tumor vs. Hematological Malignancy
2.3 Evolution of MRD Testing
2.4 Market Footprint
2.5 Market Size and Future Growth Potential
3 INDUSTRY INSIGHTS
3.1 Legal and Regulatory Framework of MRD Tests
3.1.1 Asia-Pacific
3.2 Reimbursement Scenario
3.2.1 Asia-Pacific
3.3 Supply Chain Analysis
3.3.1 For Laboratory Developed Tests (LDTs)
3.3.2 For In-Vitro Diagnostics (IVDs)
4 MINIMAL RESIDUAL DISEASE TESTING MARKET (BY REGION), 2022-2033
4.1 Overview
4.2 Asia-Pacific
4.2.1 Asia-Pacific MRD Testing Market, by End User
4.2.2 Asia-Pacific MRD Testing Market, by Country
5 COMPANY PROFILES
5.1 Overview
5.2 Sysmex Corporation
5.2.1 Company Overview
5.2.2 Role of Sysmex Corporation in the MRD Testing Market
5.2.3 Financials
5.2.4 Analyst Perspective
LIST OF FIGURES
Figure 1: Asia-Pacific MRD Testing Market, $Billion, 2022 and 2033
Figure 2: Share of Asia-Pacific MRD Testing Market (by End User), $Billion, 2022 and 2033
Figure 3: Share of MRD Testing Market (by Region), 2022
Figure 4: MRD Testing Market: Research Methodology
Figure 5: Primary Research Methodology
Figure 6: Bottom-Up Approach (Segment-Wise Analysis)
Figure 7: Top-Down Approach (Segment-Wise Analysis)
Figure 8: MRD Testing Workflow
Figure 9: Evolution of the MRD Testing Market
Figure 10: Asia-Pacific MRD Testing Market Potential, $Billion, 2022-2033
Figure 11: Supply Chain Analysis of Laboratory-Developed Tests
Figure 12: Supply Chain Analysis of In-Vitro Diagnostics
Figure 13: MRD Testing Market Snapshot (by Region)
Figure 14: Asia-Pacific: Market Dynamics
Figure 15: Asia-Pacific MRD Testing Market, $Billion, 2022-2033
Figure 16: Asia-Pacific MRD Testing Market (by End User), $Million, 2022-2033
Figure 17: Asia-Pacific MRD Testing Market (by Country), $Million, 2022-2033
Figure 18: China MRD Testing Market, $Million, 2022-2033
Figure 19: India MRD Testing Market, $Million, 2022-2033
Figure 20: Japan MRD Testing Market, $Million, 2022-2033
Figure 21: South Korea MRD Testing Market, $Million, 2022-2033
Figure 22: Australia MRD Testing Market, $Million, 2022-2033
Figure 23: Singapore MRD Testing Market, $Million, 2022-2033
Figure 24: Rest-of-Asia-Pacific MRD Testing Market, $Million, 2022-2033
Figure 25: MRD Testing Market, Total Number of Companies Profiled
Figure 26: Sysmex Corporation: Product Portfolio
Figure 27: Sysmex Corporation: Overall Financials, $Million, 2020-2022
Figure 28: Sysmex Corporation: Revenue (by Segment), $Million, 2020-2022
Figure 29: Sysmex Corporation: Revenue (by Region), $Million, 2020-2022
Figure 30: Sysmex Corporation: R&D Expenditure, $Million, 2020-2022
Figure 1: Asia-Pacific MRD Testing Market, $Billion, 2022 and 2033
Figure 2: Share of Asia-Pacific MRD Testing Market (by End User), $Billion, 2022 and 2033
Figure 3: Share of MRD Testing Market (by Region), 2022
Figure 4: MRD Testing Market: Research Methodology
Figure 5: Primary Research Methodology
Figure 6: Bottom-Up Approach (Segment-Wise Analysis)
Figure 7: Top-Down Approach (Segment-Wise Analysis)
Figure 8: MRD Testing Workflow
Figure 9: Evolution of the MRD Testing Market
Figure 10: Asia-Pacific MRD Testing Market Potential, $Billion, 2022-2033
Figure 11: Supply Chain Analysis of Laboratory-Developed Tests
Figure 12: Supply Chain Analysis of In-Vitro Diagnostics
Figure 13: MRD Testing Market Snapshot (by Region)
Figure 14: Asia-Pacific: Market Dynamics
Figure 15: Asia-Pacific MRD Testing Market, $Billion, 2022-2033
Figure 16: Asia-Pacific MRD Testing Market (by End User), $Million, 2022-2033
Figure 17: Asia-Pacific MRD Testing Market (by Country), $Million, 2022-2033
Figure 18: China MRD Testing Market, $Million, 2022-2033
Figure 19: India MRD Testing Market, $Million, 2022-2033
Figure 20: Japan MRD Testing Market, $Million, 2022-2033
Figure 21: South Korea MRD Testing Market, $Million, 2022-2033
Figure 22: Australia MRD Testing Market, $Million, 2022-2033
Figure 23: Singapore MRD Testing Market, $Million, 2022-2033
Figure 24: Rest-of-Asia-Pacific MRD Testing Market, $Million, 2022-2033
Figure 25: MRD Testing Market, Total Number of Companies Profiled
Figure 26: Sysmex Corporation: Product Portfolio
Figure 27: Sysmex Corporation: Overall Financials, $Million, 2020-2022
Figure 28: Sysmex Corporation: Revenue (by Segment), $Million, 2020-2022
Figure 29: Sysmex Corporation: Revenue (by Region), $Million, 2020-2022
Figure 30: Sysmex Corporation: R&D Expenditure, $Million, 2020-2022
LIST OF TABLES
Table 1: Impact Analysis of Market Drivers, Challenges, and Opportunities in the MRD Testing Market
Table 2: Comparison of Solid Tumor and Hematological Malignancy for MRD Testing
Table 3: Registration Criteria for IVD Medical Devices as per CFDA
Table 1: Impact Analysis of Market Drivers, Challenges, and Opportunities in the MRD Testing Market
Table 2: Comparison of Solid Tumor and Hematological Malignancy for MRD Testing
Table 3: Registration Criteria for IVD Medical Devices as per CFDA
